StartupsNov 11, 2026, 7:32 AM UTC·1 min read

Biomoneta Eyes $3M to Take FDA-Cleared Air Purifier Global

Biomoneta, maker of an FDA-cleared device that kills airborne microbes in hospitals, has US$3 million in new funding on the horizon to expand globally.

A hospital-grade air disinfection device installed in a hospital ward to kill airborne microbes. — Image: techinasia.com

Biomoneta is preparing to expand beyond its home market with about US$3 million in new funding on the horizon. The company makes a hospital-grade device that kills airborne microbes and has been cleared by the US Food and Drug Administration (FDA).

According to the company, the goal is to bring its infection prevention technology to global markets. The funding has not yet closed, and details such as investors, valuation and target regions were not provided.

Why it matters

Airborne pathogens are a persistent challenge for hospitals, where infections acquired in care settings put vulnerable patients at risk. A device that has cleared FDA review gives Biomoneta a regulatory credential that can help in conversations with hospital buyers, although approval requirements differ from country to country.

What comes next

Once the round is finalised, Biomoneta is expected to put the capital toward its international push. Further specifics on rollout plans and timing have not been disclosed.

Apps worth a look

SUMO: the number puzzle

Tap the right tiles, add them up, hit the target. Easy to learn, hard to master. Free, for all ages.

Dialo: learn languages by speaking

Talk to an AI conversation partner; every sentence comes back corrected and explained in your language. 9 languages, A1 to C2.

ediviewer: read EDI files like documents

Open EDIFACT and X12 messages, see every segment explained, convert to JSON/XML, export PDF and Excel. Runs locally, no upload.

giftdetect: the right gift in minutes

Pick who it is for, the occasion and their personality. The search engine reads product descriptions from local shops and ranks what fits. Free, no sign-up.

Tags:biomonetafdahealthtechinfection preventionfunding